No significant change in the expression of the three IFN responsive genes was observed in this transgenic mouse model of Alzheimer's disease at the terminal stage of the disease when compared to age matched isogenic controls (Figure 1B). This evidence concerns the gene IFNA1 and early-onset autosomal dominant Alzheimer disease.